Alcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGeneticPredispositionNeoplasmCachexiaLumpectomyAdjuvantTherapyImmunotherapy1 in 8womenAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenInvasiveBreastCancerFibroadenomaSelf-examinationHormoneReplacementTherapyAnastrozoleGermlineMutationBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55RelapseMultifocalTumorsMethotrexateEGFR(epidermalgrowth factorreceptor)FamilyHistoryLymphNodeStatusLCISEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearTripleNegativeBreastCancerCytostaticGeneMutationRADBevacizumabPI3KinaseInhibitorsDimplingRadiotherapyCDK4/6InhibitorsPrecisionMedicineGeneticCounselingBI-RADSLymphoscintigraphyTriplePositiveBreastCancerAyurveda5-FluorouracilAlopeciaAngiogenesisPagetDiseaseMetastasisCAMCheckpointInhibitorChemopreventionCMFChemotherapyGailModelBiopsyApoptosisBOCAPalpationCalcificationsAntibodyTherapyMegestrolAcetatePathologicResponseChemotherapyPhysicalactivity mayreduce therisk of breastcancersDoxorubicinAdvocacyHER-2HormoneReceptorStatusER+BRCAGeneCyclophosphamideProgestinEstradiolPaclitaxelTumorGradePhyllodesTumorOvarianSuppressionCapecitabineIn-situCarcinomaMorpheaSERMER-FISHDown-StagingBrachytherapyKappaEpsilonmTORInhibitorsLumpIntraductalPapillomaWomen ages40+ shouldhave a clinicalbreast examat least yearlyNodePositiveHerceptinECOGScoreExcisionalBiopsyCo-survivorPalbociclibPARPInhibitorsCystRaloxifeneKi-67RateBreastCancerCytotoxicBilateralProphylacticMastectomyMastodyniaTamoxifenWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.StagingDoseDenseTherapyMastectomyAromataseInhibitorsTyrosine-KinaseInhibitorFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AbsoluteRiskBreastTomosynthesisDocetaxelACChemotherapyOligometastasesGuaranteedRenewableInsuranceLapatinibMRIGenomicTestingDefinitiveSurgeryFlowCytometryAxillarySamplingAntiemeticNodeNegativeAdenocarcinomaMultimodalityTherapyEstrogenNeoadjuvantTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerGeneticPredispositionNeoplasmCachexiaLumpectomyAdjuvantTherapyImmunotherapy1 in 8womenAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenInvasiveBreastCancerFibroadenomaSelf-examinationHormoneReplacementTherapyAnastrozoleGermlineMutationBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55RelapseMultifocalTumorsMethotrexateEGFR(epidermalgrowth factorreceptor)FamilyHistoryLymphNodeStatusLCISEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearTripleNegativeBreastCancerCytostaticGeneMutationRADBevacizumabPI3KinaseInhibitorsDimplingRadiotherapyCDK4/6InhibitorsPrecisionMedicineGeneticCounselingBI-RADSLymphoscintigraphyTriplePositiveBreastCancerAyurveda5-FluorouracilAlopeciaAngiogenesisPagetDiseaseMetastasisCAMCheckpointInhibitorChemopreventionCMFChemotherapyGailModelBiopsyApoptosisBOCAPalpationCalcificationsAntibodyTherapyMegestrolAcetatePathologicResponseChemotherapyPhysicalactivity mayreduce therisk of breastcancersDoxorubicinAdvocacyHER-2HormoneReceptorStatusER+BRCAGeneCyclophosphamideProgestinEstradiolPaclitaxelTumorGradePhyllodesTumorOvarianSuppressionCapecitabineIn-situCarcinomaMorpheaSERMER-FISHDown-StagingBrachytherapyKappaEpsilonmTORInhibitorsLumpIntraductalPapillomaWomen ages40+ shouldhave a clinicalbreast examat least yearlyNodePositiveHerceptinECOGScoreExcisionalBiopsyCo-survivorPalbociclibPARPInhibitorsCystRaloxifeneKi-67RateBreastCancerCytotoxicBilateralProphylacticMastectomyMastodyniaTamoxifenWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.StagingDoseDenseTherapyMastectomyAromataseInhibitorsTyrosine-KinaseInhibitorFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AbsoluteRiskBreastTomosynthesisDocetaxelACChemotherapyOligometastasesGuaranteedRenewableInsuranceLapatinibMRIGenomicTestingDefinitiveSurgeryFlowCytometryAxillarySamplingAntiemeticNodeNegativeAdenocarcinomaMultimodalityTherapyEstrogenNeoadjuvantTherapyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  2. Genetic Predisposition
  3. Neoplasm
  4. Cachexia
  5. Lumpectomy
  6. Adjuvant Therapy
  7. Immunotherapy
  8. 1 in 8 women
  9. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  10. Invasive Breast Cancer
  11. Fibroadenoma
  12. Self-examination
  13. Hormone Replacement Therapy
  14. Anastrozole
  15. Germline Mutation
  16. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  17. Relapse
  18. Multifocal Tumors
  19. Methotrexate
  20. EGFR (epidermal growth factor receptor)
  21. Family History
  22. Lymph Node Status
  23. LCIS
  24. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  25. Triple Negative Breast Cancer
  26. Cytostatic
  27. Gene Mutation
  28. RAD
  29. Bevacizumab
  30. PI3 Kinase Inhibitors
  31. Dimpling
  32. Radiotherapy
  33. CDK4/6 Inhibitors
  34. Precision Medicine
  35. Genetic Counseling
  36. BI-RADS
  37. Lymphoscintigraphy
  38. Triple Positive Breast Cancer
  39. Ayurveda
  40. 5-Fluorouracil
  41. Alopecia
  42. Angiogenesis
  43. Paget Disease
  44. Metastasis
  45. CAM
  46. Checkpoint Inhibitor
  47. Chemoprevention
  48. CMF Chemotherapy
  49. Gail Model
  50. Biopsy
  51. Apoptosis
  52. BOCA
  53. Palpation
  54. Calcifications
  55. Antibody Therapy
  56. Megestrol Acetate
  57. Pathologic Response
  58. Chemotherapy
  59. Physical activity may reduce the risk of breast cancers
  60. Doxorubicin
  61. Advocacy
  62. HER-2
  63. Hormone Receptor Status
  64. ER+
  65. BRCA Gene
  66. Cyclophosphamide
  67. Progestin
  68. Estradiol
  69. Paclitaxel
  70. Tumor Grade
  71. Phyllodes Tumor
  72. Ovarian Suppression
  73. Capecitabine
  74. In-situ Carcinoma
  75. Morphea
  76. SERM
  77. ER-
  78. FISH
  79. Down-Staging
  80. Brachytherapy
  81. Kappa Epsilon
  82. mTOR Inhibitors
  83. Lump
  84. Intraductal Papilloma
  85. Women ages 40+ should have a clinical breast exam at least yearly
  86. Node Positive
  87. Herceptin
  88. ECOG Score
  89. Excisional Biopsy
  90. Co-survivor
  91. Palbociclib
  92. PARP Inhibitors
  93. Cyst
  94. Raloxifene
  95. Ki-67 Rate
  96. Breast Cancer
  97. Cytotoxic
  98. Bilateral Prophylactic Mastectomy
  99. Mastodynia
  100. Tamoxifen
  101. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  102. Staging
  103. Dose Dense Therapy
  104. Mastectomy
  105. Aromatase Inhibitors
  106. Tyrosine-Kinase Inhibitor
  107. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  108. Absolute Risk
  109. Breast Tomosynthesis
  110. Docetaxel
  111. AC Chemotherapy
  112. Oligometastases
  113. Guaranteed Renewable Insurance
  114. Lapatinib
  115. MRI
  116. Genomic Testing
  117. Definitive Surgery
  118. Flow Cytometry
  119. Axillary Sampling
  120. Antiemetic
  121. Node Negative
  122. Adenocarcinoma
  123. Multimodality Therapy
  124. Estrogen
  125. Neoadjuvant Therapy
  126. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt